tiprankstipranks
Trending News
More News >
Humacyte assumed with a Buy at H.C. Wainwright
PremiumThe FlyHumacyte assumed with a Buy at H.C. Wainwright
3d ago
Humacyte price target lowered to $14 from $17 at Benchmark
Premium
The Fly
Humacyte price target lowered to $14 from $17 at Benchmark
3d ago
Humacyte’s Promising Growth: Strong Financials and Successful Symvess Launch Drive Buy Rating
Premium
Ratings
Humacyte’s Promising Growth: Strong Financials and Successful Symvess Launch Drive Buy Rating
3d ago
Insider Moves: Humacyte, Aeva, Copart, Transdigm, Rockwell
PremiumWeekend UpdatesInsider Moves: Humacyte, Aeva, Copart, Transdigm, Rockwell
28d ago
Humacyte Challenges FDA Petition Amidst Controversy
Premium
Company Announcements
Humacyte Challenges FDA Petition Amidst Controversy
29d ago
Humacyte’s Promising Market Penetration and Revenue Projections Justify Buy Rating
Premium
Ratings
Humacyte’s Promising Market Penetration and Revenue Projections Justify Buy Rating
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
1M ago
Humacyte’s Earnings Call: Balancing Achievements and Challenges
Premium
Company Announcements
Humacyte’s Earnings Call: Balancing Achievements and Challenges
2M ago
Humacyte Stock (HUMA) Hits Record Low Post Q4 Results Despite FDA Nod for Vascular Trauma Treatment
Premium
Market News
Humacyte Stock (HUMA) Hits Record Low Post Q4 Results Despite FDA Nod for Vascular Trauma Treatment
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100